A plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 9, 2013, Pages 2048-2058

  D'Alessandro, Sarah ^a   Silvestrini, Francesco ^b   Dechering, Koen ^c   Corbett, Yolanda ^a   Parapini, Silvia ^a   Timmerman, Martijn ^c   Galastri, Laura ^d   Basilico, Nicoletta ^a   Sauerwein, Robert ^e   Alano, Pietro ^b   Taramelli, Donatella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Current affiliation: TropIQ Health Sciences   (Netherlands)

^d Associazione Volontari Italiani Sangue Comunale   (Italy)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Drug screening; Gametocytes; Malaria

Indexed keywords

CHLOROQUINE; DIHYDROARTEMISININ; EPOXOMICIN; LACTATE DEHYDROGENASE; METHYLENE BLUE; N ACETYLGLUCOSAMINE; PRIMAQUINE; PUROMYCIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SENSITIVITY; FEEDING; GAMETOCYTE; GAMETOGENESIS; GIEMSA STAIN; IN VITRO STUDY; MOSQUITO; NONHUMAN; OOCYST; PLASMODIUM FALCIPARUM;

DRUG SCREENING; GAMETOCYTES; MALARIA;

ANIMALS; ANTIMALARIALS; CELL SURVIVAL; COLORIMETRY; DRUG EVALUATION, PRECLINICAL; HUMANS; L-LACTATE DEHYDROGENASE; PLASMODIUM FALCIPARUM;

EID: 84882580906     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt165     Document Type: Article

References (34)

1. World Health Organization. World Malaria Report 2011. ISBN: 9789241564403. http://www.who.int/malaria/publications/atoz/9789241564403/en/index.html (04 April 2013, date last accessed).
2. World Health Organization. 2010. Guidelines for the Treatment of Malaria (Second Edition). ISBN: 9789241547925. http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html (04 April 2013, date last accessed).
3. Roll Back Malaria Partnership 2008. The Global Malaria Action Plan-For a Malaria Free World. http://www.rbm.who.int/gmap/gmap.pdf (04 April 2013, date last accessed).
4. Roll Back Malaria Partnership 2011. Refined/Updated GMAP Objectives, Targets, Milestones and Priorities Beyond 2011. http://www.rbm.who.int/gmap/gmap2011update.pdf (04 April 2013, date last accessed).
5. Alonso PL, Brown G, Arevalo-Herrera M et al. A research agenda to underpin malaria eradication. PLoS Med 2011; 8: e1000406.
6. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar J 2008; 7 Suppl 1: S8.
7. Roncalés M, Vidal-Mas J, Leroy D et al. Comparison and optimization of different methods for the in vitro production of Plasmodium falciparum gametocytes. J Parasitol Res 2012; 2012: 927148.
8. Lucantoni L, Avery V. Whole-cell in vitro screening for gametocytocidal compounds. Future Med Chem 2012; 4: 2337-60.
9. Adjalley SH, Johnston GL, Li T et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci USA 2011; 108: E1214-23.
10. Peatey CL, Spicer TP, Hodder PS et al. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. Mol Biochem Parasitol 2011; 180: 127-31.
11. Buchholz K, Burke TA, Williamson KC et al. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis 2011; 203: 1445-53.
12. Trager W, Jensen JB. Human malaria parasites in continuous culture. 1976. J Parasitol 2005; 91: 484-6.
13. KariukiMM, KiairaJK, MulaaFKet al. Plasmodiumfalciparum: purification of the various gametocyte developmental stages from in vitro-cultivated parasites. Am J Trop Med Hyg 1998; 59: 505-8.
14. Garcia GE, Wirtz RA, Barr JRet al. Xanthurenic acid induces gametogenesis in Plasmodium, themalaria parasite. J Biol Chem1998; 273: 12003-5.
15. Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 1993; 48: 205-10.
16. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4: 67-73.
17. van Pelt-Koops JC, Pett HE, Graumans Wet al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob Agents Chemother 2012; 56: 3544-8.
18. Pukrittayakamee S, Chotivanich K, Chantra A et al. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 2004; 48: 1329-34.
19. Czesny B, Goshu S, Cook JL et al. The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrob Agents Chemother 2009; 53: 4080-5.
20. Sinden RE, Smalley ME. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology 1979; 79: 277-96.
21. Benoit-Vical F, Lelièvre J, BerryA et al. Trioxaquines arenewantimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother 2007; 51: 1463-72.
22. GamoFJ, SanzLM, Vidal J et al. Thousandsof chemical starting points for antimalarial lead identification. Nature 2010; 465: 305-10.
23. Oduola AM, Omitowoju GO, Sowunmi A et al. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol 1997; 87: 283-9.
24. Mueller I, Betuela I, Ginny M et al. The sensitivity of the OptiMAL rapid diagnostic test to the presence of Plasmodium falciparum gametocytes compromises its ability to monitor treatment outcomes in an area of Papua New Guinea in which malaria is endemic. J Clin Microbiol 2007; 45: 627-30.
25. Tanaka TQ, Williamson KC. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol Biochem Parasitol 2011; 177: 160-3.
26. Lelièvre J, Almela MJ, Lozano S et al. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence 'transmission blocking' assay. PLoS One 2012; 7: e35019.
27. Vivas L, EastonA, KendrickHet al. Plasmodiumfalciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase. Exp Parasitol 2005; 111: 105-14.
28. Dechy-Cabaret O, Benoit-Vical F. Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate. J Med Chem 2012; 55: 10328-44.
29. Zoungrana A, Coulibaly B, Sié A et al. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One 2008; 3: e1630.
30. Coulibaly B, Zoungrana A, Mockenhaupt FP et al. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One 2009; 4: e5318.
31. Sutanto I, Suprijanto S, Kosasih A et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South Sumatra, Western Indonesia: an open label randomized controlled trial. Clin Infect Dis 2012; 56: 685-93.
32. Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur J Med Chem 2009; 44: 937-53.
33. Kiszewski AE. Blocking Plasmodium falciparum malaria transmission with drugs: the gametocytocidal and sporontocidal properties of current and prospective antimalarials. Pharmaceuticals 2010; 4: 44-68.
34. Chevalley S, Coste A, Lopez A et al. Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytes. Malar J 2010; 9: 49.